564 related articles for article (PubMed ID: 27592701)
1. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
Yoshihara M; Hayashizaki Y; Murakawa Y
Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
[TBL] [Abstract][Full Text] [Related]
2. Genomic Instability of iPSCs and Challenges in Their Clinical Applications.
Yoshihara M; Oguchi A; Murakawa Y
Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780
[TBL] [Abstract][Full Text] [Related]
3. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
5. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
[No Abstract] [Full Text] [Related]
6. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
Liu G; David BT; Trawczynski M; Fessler RG
Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
[TBL] [Abstract][Full Text] [Related]
7. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
8. Genomic stability during cellular reprogramming: Mission impossible?
von Joest M; Búa Aguín S; Li H
Mutat Res; 2016 Jun; 788():12-6. PubMed ID: 26851988
[TBL] [Abstract][Full Text] [Related]
9. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
[TBL] [Abstract][Full Text] [Related]
10. Experimental approaches for the generation of induced pluripotent stem cells.
Sommer CA; Mostoslavsky G
Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
[TBL] [Abstract][Full Text] [Related]
11. Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.
Hong SG; Dunbar CE; Winkler T
Mol Ther; 2013 Feb; 21(2):272-81. PubMed ID: 23207694
[TBL] [Abstract][Full Text] [Related]
12. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
Steichen C; Luce E; Maluenda J; Tosca L; Moreno-Gimeno I; Desterke C; Dianat N; Goulinet-Mainot S; Awan-Toor S; Burks D; Marie J; Weber A; Tachdjian G; Melki J; Dubart-Kupperschmitt A
Stem Cells Transl Med; 2014 Jun; 3(6):686-91. PubMed ID: 24736403
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
Ji J; Sharma V; Qi S; Guarch ME; Zhao P; Luo Z; Fan W; Wang Y; Mbabaali F; Neculai D; Esteban MA; McPherson JD; Batada NN
Stem Cell Reports; 2014 Jan; 2(1):44-51. PubMed ID: 24511469
[TBL] [Abstract][Full Text] [Related]
14. An Insight into Reprogramming Barriers to iPSC Generation.
Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
16. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
17. Steps toward safe cell therapy using induced pluripotent stem cells.
Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
[TBL] [Abstract][Full Text] [Related]
18. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
19. [Reprogramming mechanism and genetic stability of induced pluripotent stem cells (iPSCs)].
Ren C; Sun H; Wang L; Zhang G; Fan Y; Yan G; Wang D; Wang F
Yi Chuan; 2014 Sep; 36(9):879-87. PubMed ID: 25252305
[TBL] [Abstract][Full Text] [Related]
20. Molecular Obstacles to Clinical Translation of iPSCs.
Tapia N; Schöler HR
Cell Stem Cell; 2016 Sep; 19(3):298-309. PubMed ID: 27452174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
